##  [Guangdong Provincial Drug Administration (Guangzhou, China) Prepares 15th Five-Year Plan for Drug Supervision](/index%2ephp/mandate/guangdong-provincial-drug-administration-guangzhou-china-prepares-15th-five-year-plan-for-drug-supervision) 

October 13, 2025

The **Guangzhou-based** Guangdong Provincial Drug Administration in **China** held a work conference on **28-Sep-2025** to discuss the preparation of the province’s **15th Five-Year Plan** for drug supervision. The meeting highlighted achievements from the **14th Five-Year Plan** and emphasized the need for stronger leadership, in-depth research, and enhanced drug supervision capabilities to ensure high-quality outcomes aligned with international standards and safety regulations.

Key highlights include:

- **Collaborative Planning:** Officials from multiple levels of the market supervision bureau attended both online and offline sessions to ensure an inclusive planning process.
- **14th Five-Year Plan Achievements:** The province’s drug supervision system successfully implemented the 'four strictest' requirements, achieving significant progress.
- **Focus for 15th Five-Year Plan:** Safety risk prevention, reform implementation, and strengthening regulatory alignment with Hong Kong, Macao, and global standards.

**Freyr can help** pharmaceutical companies stay informed about provincial Regulatory plans in China, align strategies with evolving supervision requirements, and ensure compliance with drug safety and quality standards.



[Consult Now](/webform/consult?url=https://preprod.freyrsolutions.com/index%2ephp/mandate/guangdong-provincial-drug-administration-guangzhou-china-prepares-15th-five-year-plan-for-drug-supervision)



Source

<https://mpa.gd.gov.cn/xwdt/sjdt/content/post_4783423.html/>

 

 

Select Mandate HA

[NMPA](/index%2ephp/mandate-by-ha/nmpa)

 

Select Mandate Function

[Country Regulatory Affairs](/index%2ephp/mandate-by-function/country-regulatory-affairs)